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Abstract
Background:  The active hormonal form of vitamin D (1,25-dihydroxyvitamin D) is the primary
regulator of intestinal calcium absorption efficiency. In vitamin D deficiency, intestinal calcium
absorption is low leading to an increased risk of developing negative calcium balance and bone loss.
1,25-dihydroxyvitamin D has been shown to stimulate calcium absorption in experimental animals
and in human subjects. However, the molecular details of calcium transport across the enterocyte
are not fully defined. Recently, two novel epithelial calcium channels (CaT1/ECaC2 and ECaC1/
CaT2) have been cloned and suggested to be important in regulating intestinal calcium absorption.
However, to date neither gene has been shown to be regulated by vitamin D status. We have
previously shown that 1,25-dihydroxyvitamin stimulates transcellular calcium transport in Caco-2
cells, a human intestinal cell line.
Results:  In the current study, we have demonstrated that Caco-2 cells express low but detectable
levels of CaT1 mRNA in the absence of 1,25-dihydroxyvitamin D treatment. CaT1 mRNA
expression is rapidly up regulated (4-fold increase at 4 h and 10-fold at 24 h) by treatment with
1,25-dihydroxyvitamin D (10-7 moles/L). Moreover, the increase in CaT1 mRNA expression
preceded by several hours the vitamin D induction of calbindin D9K, a putative cytosolic calcium
transport protein.
Conclusion:  These observations are the first to demonstrate regulation of CaT1 expression by
vitamin D and are consistent with a new model of intestinal calcium absorption wherein vitamin D-
mediated changes in brush border membrane CaT1 levels could be the primary gatekeeper
regulating homeostatic modulation of intestinal calcium absorption efficiency.
Background
Low intestinal calcium absorption efficiency in humans
is common and contributes to negative calcium balance
and bone loss [1]. Recent epidemiological evidence sug-
gests that low fractional calcium absorption is a signifi-
cant risk factor for future osteoporotic hip fracture [2].
The primary homeostatic mechanism for altering calci-
um absorption in response to low dietary calcium intake
and increased calcium requirements during growth is an
increase in plasma 1,25-dihydroxyvitamin D, the active
hormonal form of vitamin D produced in the kidney [3].
1,25-dihydroxyvitamin D is a seco-steroid that acts on
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gene transcription through a nuclear steroid receptor
protein and also may have nongenomic actions mediated
by a putative plasma membrane vitamin D receptor [4].
Changes in vitamin D status primarily alter the rate of Ca
absorption in the proximal small intestine. During tran-
scellular calcium transport across the absorptive entero-
cyte, calcium must pass across an apical brush border
membrane, then transverse the interior of the cell, and
exit against an electrochemical gradient across the baso-
lateral membrane. Changes in the rate of vectorial Ca
transport in the intestine however must be accomplished
without a major disruption in the free intracellular Ca
concentration, which is used as an important intracellu-
lar signal in the enterocyte [5] as in other cells.
It has been known for over 30 years that vitamin D status
influences the level of calbindin D, a cytosolic calcium-
binding protein [6] believed to be the rate-limiting step
in calcium absorption [7] by acting as an intracellular
calcium ferry or chaperone. Calcium extrusion at the ba-
solateral membrane is an active process involving a Ca-
ATPase that may also be affected by vitamin D status [8].
However, although it has been known for more than 20
years that the rate of Ca transport across the intestinal
brush border membrane can be increased by 1,25-dihy-
droxyvitamin D [9], the identity of the calcium transport
protein involved in Ca influx has not been ascertained.
Recently, two novel, closely related, epithelial calcium
channels, CaT1 (also known as ECaC2) and ECaC1 (also
known as CaT2), have been cloned from rat [10] and rab-
bit [11] respectively and shown to mediate calcium influx
when expressed in Xenopus oocytes. CaT1 and ECaC1 are
found in several tissues, including 1,25-dihydroxyvita-
min D-responsive epithelia in the intestine and kidney.
These epithelial calcium channel genes are products of
evolutionary local gene duplication found on chromo-
some 7 and represent a new family of Ca-selective ion
channels involved in active Ca (re)absorption [12]. Fur-
thermore, it has been suggested that the control of the
number of active channels at the cell surface is critical for
regulation of active calcium transport and that the epi-
thelial calcium channel could confer the rate-limiting
step in transcellular calcium transport [13].
Peptide hormones and other cell surface-acting signal
molecules trigger increases in the concentration of calci-
um ions inside the cell by release of calcium from stores
within the cell, or activation of Ca++ ion channels in the
plasma membrane allowing calcium to enter from out-
side the cell. One of the most common mechanisms that
regulate entry of calcium is by capacitative or store-oper-
ated calcium entry [14]. The epithelial Ca-release activat-
ed channel, ICRAC, is a highly calcium-selective plasma
membrane ion channel that is activated on lowering of
either intracellular calcium concentration or intracellu-
lar calcium stores. The CaT1 channel has been recently
expressed in mammalian CHO cells and patch clamp
studies have shown it to have the characteristics of
ICRAC[15]. Nearly ubiquitous, store-operated calcium en-
try is essential in a wide variety of cellular processes in-
cluding muscle contraction, protein secretion,
metabolism, cell differentiation, cell division and apop-
tosis [14].
Intestinal calcium absorption is increased after feeding a
low calcium diet or under conditions of increased calci-
um needs, such as during growth, via a parathyroid hor-
mone (PTH)-vitamin D mediated process [3]. A lowering
of serum calcium levels stimulates the secretion of PTH
that then activates the renal conversion of inactive 25-
hydroxyvitamin D to the active hormonal metabolite
1,25-dihydroxyvitamin D. At the intestine, 1,25-dihy-
droxyvitamin D, acting through a nuclear receptor, stim-
ulates transcription of vitamin D-mediated genes,
including calbindin D, involved in calcium transport
thereby acting as the primary hormonal regulator of ac-
tive intestinal calcium transport [3]. It is thus likely that
any putative key molecular player in calcium absorption,
such as CaT1 or ECaC1, should be a prime target for hor-
monal regulation by 1,25-dihydroxyvitamin D. However,
to date, neither CaT1 nor ECaC1 expression has been
shown to be related to serum 1,25-dihydroxyvitamin D or
vitamin D status [10,16].
We have developed [17–22] a unique human intestinal
cell culture model of vitamin D-mediated transepithelial
Ca transport using Caco-2 cells, a colon adenocarcinoma
cell line. This cell line spontaneously differentiates in
culture and expresses biochemical and morphological
characteristics of well-differentiated small intestine-like
enterocytes [17,23]. We have previously shown that
Caco-2 cells possess a classical nuclear vitamin D recep-
tor [18] that directly mediates vitamin D-dependent gene
expression [22], and exhibits a high degree of specificity
for various vitamin D metabolites and analogs [20,21].
Most importantly, in response to short-term (<24 h)
1,25-dihydroxyvitamin D treatment, Caco-2 cells in-
crease transepithelial calcium transport [17] and calbin-
din D9K expression [19], a cytosolic calcium binding
protein. Kinetic analysis of Ca transport across Caco-2
monolayers grown on permeable filter supports indicat-
ed that 1,25-dihydroxyvitamin D treatment increased the
Vmax of Ca transport [17], which would be consistent
with a vitamin D-dependent increase in the number of
calcium transporters.
In the current paper, we have used the Caco-2 cell culture
model to demonstrate that CaT1 mRNA is preferentially
expressed in the human enterocyte compared to ECaC1,
and for the first time demonstrate that 1,25-dihydroxyvi-BMC Physiology 2001, 1:11 http://www.biomedcentral.com/1472-6793/1/11
tamin D treatment can cause a rapid and marked in-
crease in CaT1 mRNA expression in the enterocyte.
These observations suggest a likely important role for
this calcium transporter in vitamin D-dependent calci-
um absorption.
Results and Discussion
CaT1 is expressed in Caco-2 cells
We initially addressed the question of whether Caco-2
cells express ECaC1 or the closely related CaT1 gene. This
is important because it has been suggested that because
of the high degree of sequence similarity (97%) between
the CaT1 and ECaC1 genes care should be taken in inter-
preting data obtained by hybridization, PCR or other
methodologies based on nucleotide sequences [24].
First, the PCR product derived from the putative ECaC1
or CaT1 gene was purified and sequenced. Based on new
sequence information (GenBank accession number
AF304464 (ECaC1) and AF365927 (CaT1), [25]) the nu-
cleotides determined following the sequencing of our
PCR product from Caco-2 cells was an identical match
for CaT1 rather than ECaC1 (data not shown). Second,
the sequences of the coding region of the CaT1 and
ECaC1 genes (GenBank AF365927 and AF304464) indi-
cate that an additional identification step based on re-
striction fragment length polymorphism (RFLP) analysis
could also be used to confirm the identity of the CaT1
mRNA in Caco-2 cells. As described in the Method sec-
tion, a 259 bp PCR product was generated with a second
set of PCR primers that would specifically encompass a
differential Bgl1 restriction enzyme cut site present in
CaT1 but not ECaC1. Prior to electrophoresis on a 2%
agarose gel, the amplified PCR product was either left
untreated, or treated with Bgl1 or BssHII restriction en-
zymes. There is no predicted BssHII cut site in our am-
plified region of either CaT1 or ECaC1 based on the
recently published sequence of these two genes (Gen-
Bank AF365927 and AF304464). Thus, BssHII should
serve as negative control for the restriction enzyme di-
gestion step. In contrast, the location of the single BglI
cut site in CaT1 should result in the generation of two
smaller bands (≅  180 bp and ≅  80 bp) if the amplified
PCR product was CaT1. Since ECaC1 does not have a pre-
dicted BglI site in the amplified PCR product, no smaller
bands should result if ECaC1 was being amplified in the
PCR reaction. As shown in Figure 1, we found that there
were two smaller bands of the predicted size and no larg-
er 259 bp band remaining after Bgl1 digestion, confirm-
ing the identity of CaT1 as the product being amplified in
Caco-2 cell. In addition, BssHII restriction enzyme di-
gestion did not result in smaller bands, consistent with a
likely specific action of Bgl1 digestion of CaT1 under the
digestion conditions used. In addition, further attempts
at PCR amplification of Caco-2 cell RNA with other PCR
primers designed to specifically amplify ECaC1 did not
result in an amplified product under our conditions (data
not shown). Thus, based on this collective information,
we conclude that CaT1, but not ECaC1, is expressed in
Caco-2 cells. It needs to be pointed out, however, that
since Caco-2 cells are not derived from normal human
intestinal tissue, it is possible that ECaC1 could be ex-
pressed in the human intestine. However, our observa-
tion in Caco-2 cells is consistent with the recent report by
Barley and colleagues [16] indicating a high expression
level of CaT1/ECaC2 in human intestine based on North-
ern blotting, and similar findings by Peng et al. [25] us-
ing quantitative real-time PCR for CaT1, who also noted
the apparent absence of ECaC1/CaT2 in human intesti-
nal tissue.
CaT1 mRNA is regulated by 1,25-dihydroxyvitamin D
Having established the identity of CaT1 in Caco-2 cells,
we then studied the effect of 1,25-dihydroxyvitamin D
treatment on CaT1 mRNA expression. If CaT1 is an im-
portant regulator of intestinal calcium absorption, it is
likely that it would be regulated by 1,25-dihydroxyvita-
min D. As shown in Figure 2, treatment of cells for 24 h
with 10-7 mol/L 1,25-dihydroxyvitamin D caused a 10-
fold increase (p < 0.001, ANOVA, n= 10 studies) in CaT1
mRNA expression. To our knowledge, this is the first
demonstration in either experimental animals or human
tissue that intestinal CaT1 expression is up regulated by
Figure 1
Restriction Enzyme Digest of PCR Product From
Caco-2 Cells. The amplified PCR product for the apical cal-
cium transporter from Caco-2 cells (see text) was digested
with Bgl1 or BssHII restriction enzymes. Digestion with Bgl1
resulted in the generation of two smaller appropriately sized
products (180 bp and 80 bp) as would be expected only if the
PCR product was CaT1 due to the presence of this restric-
tion enzyme cut site only in CaT1 but not ECaC1 in the
region amplified (GenBank acc. no. AF365927 nucleotide
location 545–803). BssHII digestion did not result in any
smaller bands being observed. Thus was expected since this
enzyme was not predicted to cut either CaT1 or ECaC1
(GenBank acc. no. AF304464) in the region of interest and
thereby could serve as a negative control to exclude the pos-
sibility that nonspecific fragmentation of under the restriction
digest conditions.BMC Physiology 2001, 1:11 http://www.biomedcentral.com/1472-6793/1/11
1,25-dihydroxyvitamin D. This finding may provide an
important molecular key to understand the mechanism
of vitamin D-mediated intestinal calcium absorption.
Moreover, given the potentially central role of this epi-
thelial calcium channel as an important modulator of
cellular calcium influx in a variety of cell types [15], it will
be of interest to investigate whether the vitamin D effect
on CaT1 expression extends beyond the enterocyte. Vita-
min D status is known to influence a wide range of phys-
iological systems including cells involved in the immune
system, endocrine function, prostate, skin and muscle.
Vitamin D effects on CaT1 expression and cellular calci-
um influx could thereby theoretically modulate intracel-
lular calcium and cell signaling in a variety of different
tissues providing insight into understanding the physio-
logical effects of vitamin D throughout the body. Peng
and colleagues [26] have reported that the steroid hor-
mone androgen influences CaT1 mRNA expression in
LNCaP prostate cells. We have not yet evaluated the ef-
fects of androgens on CaT1 expression in Caco-2 cells.
However, we have found (S. Taparia, unpublished stud-
ies) that all steroid hormones do not share this effect on
CaT1 expression because 17-β  estradiol (10 -7 mol/L for
24 h) had no effect on CaT1 mRNA expression in Caco-2
cells. In any case, the demonstrated effect of 1,25-dihy-
droxyvitamin D on CaT1 mRNA shown here in Caco-2
cells is consistent with the idea that the active metabolite
of vitamin D could increase the number of CaT1 calcium
transporters in the plasma membrane and could there-
fore be responsible for the higher rates of calcium influx
seen across the brush border membrane in vitamin D-re-
plete animals [9,27] thereby playing a key gatekeeper
role in increasing the efficiency of intestinal calcium ab-
sorption and maintaining calcium homeostasis.
1,25-dihydroxyvitamin D causes a rapid and marked up 
regulation of CaT1 expression
In another series of studies, we addressed the temporal
and dose-response effect of 1,25-dihydroxyvitamin D on
CaT1 mRNA expression in Caco-2 cells. As shown in Fig-
ure 3, the response of CaT1 mRNA to 1,25-dihydroxyvita-
min D is rapid (n = 6 studies). Treatment with 10-7 mol/
L 1,25-dihydroxyvitamin D increased (~2-fold) CaT1
mRNA by 2 h, the earliest time point investigated, and
clearly elevated CaT1 expression by 5-fold at 4 h, with
progressively higher expression (up to 14-fold) at the lat-
er time points.
The relationship between the dose of 1,25-dihydroxyvita-
min D treatment and CaT1 mRNA response was investi-
gated in a third set (n= 3 studies) of experiments at 10-9,
10-8, and 10-7 mol/L 1,25-dihydroxyvitamin D for 24 h.
In these studies there was a significant increase in CaT1
mRNA levels at the lowest dose (10-9 mol/L) of 1,25-di-
hydroxyvitamin D studied (Figure 4), while a slightly
higher level of CaT1 mRNA expression was observed at
10 -8 mol/L 1,25-dihydroxyvitamin D, no further effect
on CaT1 mRNA was seen with another 10-fold increase in
1,25-dihydroxyvitamin D concentration.
The rapid time course of induction and sensitivity of
CaT1 mRNA response to 1,25-dihydroxyvitamin D treat-
ment supports the idea that CaT1 could play a role as a
gatekeeper of intestinal calcium absorption. We have
previously reported that it takes from 12–16 h following
1,25-dihydroxyvitamin D treatment of Caco-2 cells to
first appreciate an increase in saturable transcellular cal-
cium transport [19]. This temporal response is similar to
the 8–16 h observed for the achievement of maximal
Figure 2
1,25-Dihydroxyvitamin D Up Regulates The Expres-
sion Of CaT1 mRNA In Caco-2 Cells. Cells were
treated with ethanol vehicle or 1,25-dihydroxyvitamin D
(100 nM, 10 -7 mol/L) for 24 h. Total RNA was harvested and
CaT1 mRNA (28 cycles) and GAPDH mRNA (21 cycles)
were determined by RT-PCR. The PCR products were elec-
trophoresed on a 2% agarose gel and stained with ethidium
bromide for visualization and digital capture. The upper pic-
ture in the illustration shows the CaT1 PCR products from 6
individual wells of a single experiment (3 control and 3 +
1,25-dihydroxyvitamin D). CaT1 expression in the gel has
been juxtaposed on top of the corresponding GAPDH
expression. GAPDH is a housekeeping gene used to stand-
ardize CaT1 mRNA expression. Low levels of CaT1 mRNA
are discernable in the absence of vitamin D treatment and
the up regulating effect of 1,25-dihydroxyvitamin D by 24 h
of treatment is clearly evident. The bar graph shows the
combined mean (SEM) effect of 1,25-dihydroxyvitamin D on
CaT1 expression normalized for GAPDH from 10 independ-
ent studies. 1,25-dihydroxyvitamin D treatment caused a sig-
nificant (p < 0.001) 10-fold increase in CaT1 mRNA
expression compared to vehicle treated control cells.BMC Physiology 2001, 1:11 http://www.biomedcentral.com/1472-6793/1/11
rates of intestinal calcium absorption in vivo following
1,25-dihydroxyvitamin D treatment of vitamin D-defi-
cient chickens [28]. Future studies of the time course of
CaT1 protein expression and localization of this protein
to the brush border will be necessary to confirm this
point, but must await the development of a suitable CaT1
antibody.
CaT1 induction precedes the increase in calbindin D9k 
mRNA expression
It has been argued [7] that the cytosolic vitamin D-de-
pendent calcium binding protein calbindin D9K is the
likely rate-limiting step in vitamin D-induced intestinal
calcium absorption. However, despite a considerable
amount of associative evidence [7], there has long been
some controversy on this issue [29–31] because of ap-
parent discrepancies in the temporal pattern of calbindin
D9k induction compared to calcium absorption follow-
ing 1,25-dihydroxyvitamin D treatment in experimental
animals. Thus, in the current study, to evaluate a possi-
ble gatekeeper role for CaT1 in vitamin D-mediated cal-
cium transport we compared the time course of 1,25-
dihydroxyvitamin D induction of calbindin D9k mRNA
and CaT1 mRNA in Caco-2 cells. In Caco-2 cells, the
mRNA for both calbindin D and CaT1 can be detected by
PCR in the absence of vitamin D treatment. The concen-
tration of 1,25-dihydroxyvitamin D in the basal cell cul-
ture medium is approximately 10 -12 mol/L. As
illustrated in Figure 5, the time course of vitamin D-de-
pendent mRNA induction of the two genes clearly differs
with CaT1 expression responding much earlier than cal-
bindin D9k. There is no evident induction of calbindin D
mRNA by 1,25-dihydroxyvitamin D in Caco-2 cells up to
8 h post treatment. In these experiments calbindin D
mRNA was 3-fold greater than control by 24 h. In con-
trast, CaT1 mRNA was clearly increased (>5-fold) by 4 h
post 1,25-dihydroxyvitamin D treatment in the same
cells. These observations will need to be expanded in the
future to include measurement of the relevant proteins.
However, such association studies will not completely
settle the question of the relative importance of either of
these vitamin D-induced genes in the calcium transport
response to 1,25-dihydroxyvitamin D. Those questions
will be likely answered more directly in the future by in-
dividually altering the expression of these calcium trans-
port genes in transfected cell lines or in transgenic
animal models.
Given what is already known about the characteristics of
the epithelial calcium channels and calbindin D, it is a
plausible hypothesis that CaT1 and calbindin D could
work in tandem to maintain high rates of calcium ab-
sorption. Studies in human duodenal biopsy specimens
have found a significant correlation between CaT1
Figure 3
Early Temporal Response of CaT1 mRNA to 1,25-
dihydroxyvitamin D in Caco-2 Cells. Caco-2 cells were
treated with 1,25-dihydroxyvitamin D (10 -7 mol/L) for 0, 2,
4, 8 or 24 h. The bar graph illustrates the mean (SEM) fold-
increase in CaT1 mRNA expression at each of the time
points from 6 independent time course studies. There was a
significant (p < 0.0001, ANOVA) time-dependent induction
of CaT1 mRNA expression by 1,25-dihydroxyvitamin D with
evidence of increased induction as early as 2 h and clear and
progressive up regulation of CaT1 expression between 4 h
and 24 h.
Figure 4
Effect of 1,25-dihydroxyvitamin D Dose on CaT1
mRNA in Caco-2 cells. Cells were treated for 24 h with
increasing doses (1–100 nM) of 1,25-dihydroxyvitamin D.
The mean effect of 1,25-dihydroxyvitamin D (n= 3 studies)
on CaT1 mRNA was evident at the lowest dose (10 -9 mol/L)
investigated. In these experiments there was a further
increase in expression at 10 -8 mol/L 1,25-dihydroxyvitamin
D, but no further increase in expression at a 10-fold higher
dose of 1,25-dihydroxyvitamin D.BMC Physiology 2001, 1:11 http://www.biomedcentral.com/1472-6793/1/11
mRNA and calbindin D mRNA expression [16]. Thus, as
a working hypothesis, we propose that during times of
dietary calcium stress, or during periods of high calcium
demand, CaT1 expression in the enterocyte is increased
by a vitamin D-dependent mechanism. This regulatory
genomic response of the enterocyte would result in an in-
crease in the brush border membrane content of CaT1
calcium influx channels that could function as a gate-
keeper mechanism to augment the rate of calcium entry
across the apical membrane [9]. However, given that
there is a Ca-dependent negative feedback mechanism to
limit calcium entry through the channel by maintaining
the channel in the closed position [14,15] there must be a
way to remove calcium from the vicinity of the cytosolic
face of the channel to optimize and sustain calcium in-
flux rates. The coordinated vitamin D-dependent induc-
tion of the cytosolic calcium-binding protein calbindin D
could serve this function when the need for transcellular
calcium flux is high by acting directly or indirectly as a
molecular sponge and selectively removing calcium ions
from the CaT1 channel and/or to buffer increases in in-
tracellular calcium, thereby preventing premature inac-
tivation of this ICRAC channel [15]. Calbindin D could
also play its traditionally conceived role as a calcium
chaperone protein to facilitate the transfer of calcium
through the cytosol [32] and perhaps delivery of Ca++ to
the basolateral ATP-dependent calcium pump for extru-
sion out of the enterocyte [33].
Conclusions
These observations are the first to demonstrate regula-
tion of CaT1 expression by 1,25-dihydroxyvitamin D in
the human enterocyte and are consistent with a new
model of intestinal calcium absorption wherein vitamin
D-mediated changes in brush border membrane CaT1
levels could be the primary gatekeeper regulating home-
ostatic modulation of intestinal calcium absorption effi-
ciency.
Materials and Methods
Conditions of cell culture
Caco-2 cells (HTB 37, ATCC, Rockville, MD) were prop-
agated and maintained as described previously [17].
Caco-2 cells were studied between passages 30–40. Cells
were seeded into six-well dishes (35-mm diameter; Cos-
tar, Cambridge, MA) and grown for 15 days. Cell culture
medium, nutrients and antibiotics were purchased from
BioWhittaker (Walkersville, MD). FBS was purchased
from HyClone Laboratories (Logan, Utah). Chemicals
were purchased from Sigma Chemical Co. (St. Louis,
MO) and 1,25-dihydroxyvitamin D was purchased from
Biomol Research Laboratories (Plymouth Meeting, PA).
Cell treatments
In time-course studies, cells were treated with 100 na-
nomol/L 1,25-dihydroxyvitamin D diluted in DMEM +
5% FBS for 0, 2 h, 4 h, 8 h and 24 h. All treatments ended
at the 24 h time point. Control treatments were treated
with ethanol vehicle alone. In dose-response studies,
cells were treated for 24 h with 0,1,10, or 100 nanomol/
L 1,25-dihydroxyvitamin D diluted in DMEM + 5% FBS.
Control cells were treated with ethanol vehicle.
Reverse transcription polymerase chain reaction (RT-PCR)
Following experimental treatments, cells were harvested
and total RNA was isolated according to manufacturer's
instructions (Tri Reagent, Molecular Research Center,
Cincinnati, OH). One microgram of total RNA was made
into a cDNA library by a reverse transcription process us-
ing the following conditions: 0.1 ug of oligothymidine,
100 U of reverse transcriptase, 5 ug bovine serum albu-
min (BSA), 10 U RNAsin (Promega, Madison WI) in a fi-
nal volume of 10 ul buffer containing 50 mM Tris-HCl
(pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothrei-
tol, 0.5 mM each of CTP, ATP, GTP, TTP, incubated for 2
h at 37°C, and denatured at 95°C for 10 minutes. The
cDNA solution containing 0.1 µg equivalent RNA was an-
alyzed by PCR for GAPDH, human calbindin D9K, and
human CaT/ECaC. Primers sets for the epithelial calci-
um channel were as follows: sense primer
5'TGAACCTGGTGCGCGCACTGC3' (GenBank accession
Figure 5
Comparison of the Time Course of CaT1 mRNA and
Calbindin D 9K mRNA Induction by 1,25-dihydroxyvi-
tamin D in Caco-2 Cells. Caco-2 cells were treated with
1,25-dihydroxyvitamin D (10 -7 mol/L) for 0, 2, 4, 8 or 24 h.
The bar graph indicates the mean (SEM) fold-increase in
CaT1 mRNA and calbindin D mRNA expression at each of
the time points. The early induction of CaT1 mRNA by 4 h
and 8 h following 1,25-dihydroxyvitamin D treatment is not
evident for calbindin D mRNA, which did not increase above
control until the 24 h time point. The data for CaT1 is the
same as presented in Figure 3.BMC Physiology 2001, 1:11 http://www.biomedcentral.com/1472-6793/1/11
number AJ271207.1 nucleotides 480–500) and anti-
sense primer 5'CCCAGGGAGTCCTGGGCCCGGA3' (nu-
cleotides 657–678). The PCR primers used for GAPDH
and calbindin D were as previously described [22]. PCR
conditions used were: denature at 94°C for 40 s, anneal-
ing at 55°C for 50 s with an extension at 72°C for 50 s. All
reactions were run within the linear range of number of
cycles to product formed. GAPDH was amplified for 21
cycles, CaT1 for 28 cycles and calbindin D9K for 28 cy-
cles. A blank PCR was run using water for each gene test-
ed. PCR products were electrophoresed on a 2% agarose
gel containing ethidium bromide. Relative amounts of
amplified PCR product from each experimental condi-
tion were visualized under ultraviolet light and digitized
with the Gel Doc 2000 gel documentation system (Bio-
Rad Laboratories, Hercules, CA). Relative amounts of
product were estimated by digital densitometry using
Quantity One (version 4) quantitation software (Bio-
Rad). CaT1 and calbindin D9K mRNA expression were
normalized relative to the expression of GAPDH mRNA,
a constitutively expressed gene whose levels were not af-
fected by 1,25-dihydroxyvitamin D treatment.
Sequencing and RFLP analysis to establish the identity of 
CaT1 in Caco-2 Cells
PCR products from the epithelial calcium channel were
generated with the primers described above, subjected to
electrophoresis on a 1% low-melting-point agarose gel,
and purified for sequence verification. The DNA se-
quencing facility at Tufts University sequenced the PCR
product to identify whether the amplified PCR product
from Caco-2 cells was either CaT1 or the closely related
ECaC1 sequence. Because of the high nucleotide similar-
ity of CaT1 and ECaC1 (97%), an additional identification
step based on restriction fragment length polymorphism
(RFLP) analysis was also conducted to confirm the iden-
tity of CaT1 in Caco-2 cells. PCR products were generated
using the following primer set: sense primer
(5'TGACATCTGAGCTCTATGAGGGT3', GenBank
AF365927 nucleotides 545–567) and antisense primer
5'CCCAGGGAGTCCTGGGCCCGGA3' (nucleotides 782–
803). These primers yield a 259 bp PCR product with a
specific restriction site that makes it possible to clearly
distinguish between CaT1 and ECaC1 using the restric-
tion enzymes Bgl1 (New England Biolabs). In this PCR
amplified product, there is no predicted Bgl1 restriction
enzyme site in the corresponding ECaC1 sequence. In
contrast, the presence of this Bgl1 cut site in the CaT1 se-
quence will result in two smaller bands (≅  180 and ≅  80
bp) after digestion with the endonuclease. The endonu-
clease digested and undigested PCR samples were elec-
trophoresed on a 2% agarose gel and the bands were
visualized with ethidium bromide staining. The size of
the cut bands was estimated with standard 50 pb mark-
ers to identify whether the PCR product amplified from
Caco-2 cells was being cut into the appropriately sized
bands with Bgl1.
Data analysis
Data are reported as mean ± the standard error of the
mean (SEM). Experiments were repeated from 3 to 10
times. Treatment effects were evaluated by ANOVA with
a post hoc Tukey test for individual treatment compari-
sons (SYSTAT version 9, SAS Institute, Cary NC) where
applicable.
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